Brain diseases are the leading cause of disability in Canadians with more than 3.6 million Canadians affected by a brain condition. With an aging population, new treatments are desperately needed.
Two of the world’s most accomplished neuroscience research initiatives at McGill and Western University have combined their expertise to convert scientific research to societal impact.
The McGill-Western Initiative for Translational Neuroscience (ITN) brings together world-renowned scientists to work on two large-scale research projects focusing on biotherapeutics and Parkinson’s Disease. This collaborative work will have immediate impact for patients living with brain diseases and disorders in Canada and around the world.
The ITN is supported by the Canada First Research Excellence Fund (CFREF) through McGill’s Healthy Brains, Healthy Lives and Western’s BrainsCAN initiatives.